Bio-Rad Laboratories (BIO) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $18.3 million.
- Bio-Rad Laboratories' Gains from Investment Securities fell 2278.48% to $18.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $81.0 million, marking a year-over-year decrease of 1851.11%. This contributed to the annual value of $81.0 million for FY2025, which is 1851.11% down from last year.
- According to the latest figures from Q4 2025, Bio-Rad Laboratories' Gains from Investment Securities is $18.3 million, which was down 2278.48% from $6.6 million recorded in Q3 2025.
- Over the past 5 years, Bio-Rad Laboratories' Gains from Investment Securities peaked at $65.5 million during Q2 2022, and registered a low of $6.6 million during Q3 2025.
- In the last 5 years, Bio-Rad Laboratories' Gains from Investment Securities had a median value of $23.6 million in 2024 and averaged $30.1 million.
- As far as peak fluctuations go, Bio-Rad Laboratories' Gains from Investment Securities skyrocketed by 104745.3% in 2021, and later tumbled by 7191.49% in 2025.
- Bio-Rad Laboratories' Gains from Investment Securities (Quarter) stood at $30.8 million in 2021, then tumbled by 33.61% to $20.4 million in 2022, then soared by 133.75% to $47.8 million in 2023, then crashed by 50.39% to $23.7 million in 2024, then dropped by 22.78% to $18.3 million in 2025.
- Its Gains from Investment Securities was $18.3 million in Q4 2025, compared to $6.6 million in Q3 2025 and $39.8 million in Q2 2025.